Karen Bräutigam

1.2k total citations
32 papers, 916 citations indexed

About

Karen Bräutigam is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Karen Bräutigam has authored 32 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Karen Bräutigam's work include Ovarian cancer diagnosis and treatment (7 papers), Cancer-related molecular mechanisms research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Karen Bräutigam is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Cancer-related molecular mechanisms research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Karen Bräutigam collaborates with scholars based in Germany, United States and South Africa. Karen Bräutigam's co-authors include Philip Rosenstiel, Stefan Schreiber, Dirk Seegert, Georg H. Waetzig, Tanja Kühbacher, Massimo Claudio Fantini, Ivo Meinhold‐Heerlein, Nicolaì Maass, Dirk Bauerschlag and Felix Zeppernick and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Clinical Cancer Research.

In The Last Decade

Karen Bräutigam

30 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Bräutigam Germany 14 345 338 190 171 165 32 916
Hongxiu Ji United States 17 440 1.3× 411 1.2× 149 0.8× 267 1.6× 117 0.7× 42 1.4k
Takahide Arimoto Japan 18 349 1.0× 274 0.8× 173 0.9× 274 1.6× 61 0.4× 49 1.0k
Seon-Ah Ha South Korea 14 447 1.3× 304 0.9× 124 0.7× 180 1.1× 55 0.3× 20 928
Di Song China 15 224 0.6× 164 0.5× 91 0.5× 160 0.9× 43 0.3× 61 807
Katsumi Tsukazaki Japan 18 452 1.3× 174 0.5× 128 0.7× 245 1.4× 85 0.5× 65 1.1k
Jane M. Turbov United States 14 515 1.5× 338 1.0× 143 0.8× 155 0.9× 104 0.6× 19 1.0k
A Hizuta Japan 16 483 1.4× 282 0.8× 96 0.5× 466 2.7× 146 0.9× 62 1.1k
Rosalía I. Cordo Russo Argentina 14 432 1.3× 547 1.6× 154 0.8× 203 1.2× 40 0.2× 27 1.1k
İlyas Şahin United States 19 516 1.5× 273 0.8× 244 1.3× 339 2.0× 41 0.2× 70 1.3k
Yoko Aoyagi Japan 19 309 0.9× 292 0.9× 103 0.5× 84 0.5× 72 0.4× 59 1.0k

Countries citing papers authored by Karen Bräutigam

Since Specialization
Citations

This map shows the geographic impact of Karen Bräutigam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Bräutigam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Bräutigam more than expected).

Fields of papers citing papers by Karen Bräutigam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Bräutigam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Bräutigam. The network helps show where Karen Bräutigam may publish in the future.

Co-authorship network of co-authors of Karen Bräutigam

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Bräutigam. A scholar is included among the top collaborators of Karen Bräutigam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Bräutigam. Karen Bräutigam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Köster, Frank, Karen Bräutigam, Achim Rody, et al.. (2025). Prognostic and clinical heterogeneity of PD1 and PD-L1- immunohistochemical scores in endometrial cancers. Archives of Gynecology and Obstetrics. 311(5). 1395–1405.
2.
Bräutigam, Karen, et al.. (2024). CER818: A Highly Specific and Sensitive HPV L1 High‐Risk Serological Lateral Flow Rapid Test for Early Detection of Cervical Cancer and Its Precursor Lesions. Infectious Diseases in Obstetrics and Gynecology. 2024(1). 6651272–6651272. 1 indexed citations
3.
Hussain, Ahmad Fawzi, Chaoyu Zhang, Karen Bräutigam, et al.. (2021). Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches. Pharmaceuticals. 14(4). 343–343. 27 indexed citations
4.
Köster, Frank, Friederike Hoellen, Julika Ribbat‐Idel, et al.. (2020). PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer. Oncology Letters. 20(1). 581–588. 11 indexed citations
5.
Bräutigam, Karen, et al.. (2019). Analysis of HPV genotype-specific concordance between EUROArray HPV and HPV 3.5 LCD-Array Kit in cervical samples of 163 patients. Archives of Gynecology and Obstetrics. 301(3). 745–751. 1 indexed citations
6.
Bauerschlag, Dirk, Ivo Meinhold‐Heerlein, Nicolaì Maass, et al.. (2017). Detection and Specific Elimination of EGFR+ Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic Approach. Pharmaceutical Research. 34(4). 696–703. 24 indexed citations
7.
Bräutigam, Karen, et al.. (2016). Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate.. PubMed. 36(6). 2759–66. 9 indexed citations
8.
Felbert, Verena von, Dirk Bauerschlag, Nicolaì Maass, et al.. (2016). A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR. Journal of Cancer Research and Clinical Oncology. 142(5). 1003–1011. 32 indexed citations
9.
Bauerschlag, Dirk, Felix Zeppernick, Verena von Felbert, et al.. (2016). Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand. Oncotarget. 7(34). 54925–54936. 27 indexed citations
10.
Bauerschlag, Dirk, Nicolaì Maass, P Leonhardt, et al.. (2015). Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer. Journal of Translational Medicine. 13(1). 146–146. 106 indexed citations
11.
Wölfler, Monika, Ivo Meinhold‐Heerlein, Corinna Henkel, et al.. (2013). Reduced hemopexin levels in peritoneal fluid of patients with endometriosis. Fertility and Sterility. 100(3). 777–781.e2. 26 indexed citations
12.
Meinhold‐Heerlein, Ivo, Karen Bräutigam, Ulrich Pecks, Nicolaì Maass, & Dirk Bauerschlag. (2013). Prognostische und prädiktive Marker des Ovarialkarzinoms. Der Gynäkologe. 46(6). 386–391.
13.
Bauerschlag, Dirk, Karen Bräutigam, Roland Moll, et al.. (2012). Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary. Journal of Cancer Research and Clinical Oncology. 139(2). 347–355. 3 indexed citations
14.
Bauerschlag, Dirk, Ole Ammerpohl, Karen Bräutigam, et al.. (2011). Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles. Oncology. 80(1-2). 12–20. 39 indexed citations
15.
Bräutigam, Karen, Dirk Bauerschlag, Constantin S. von Kaisenberg, et al.. (2010). Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. Journal of Cancer Research and Clinical Oncology. 137(5). 875–886. 26 indexed citations
16.
Bräutigam, Karen, Dirk Bauerschlag, Marion T. Weigel, et al.. (2009). Combination of Enzastaurin and Pemetrexed Inhibits Cell Growth and Induces Apoptosis of Chemoresistant Ovarian Cancer Cells Regulating Extracellular Signal-Regulated Kinase 1/2 Phosphorylation. Translational Oncology. 2(3). 164–IN1. 15 indexed citations
17.
Meinhold‐Heerlein, Ivo, Dirk Bauerschlag, Yingyao Zhou, et al.. (2007). An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma. Clinical Cancer Research. 13(2). 458–466. 41 indexed citations
18.
Hammer, Suntrea T.G., Natalie Arnold, Felix Hilpert, et al.. (2007). 5009 ORAL Significant antitumour activity of the novel epothilone ZK-EPO against in vitro and in vivo models of ovarian cancer. European Journal of Cancer Supplements. 5(4). 313–314. 3 indexed citations
19.
Meinhold‐Heerlein, Ivo, Karen Bräutigam, Christoph Mundhenke, et al.. (2006). Effects of PKC beta inhibitor enzastaurin on parental and chemoresistant ovarian cancer cell lines. Journal of Clinical Oncology. 24(18_suppl). 20037–20037. 4 indexed citations
20.
Rosenstiel, Philip, Massimo Claudio Fantini, Karen Bräutigam, et al.. (2003). TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology. 124(4). 1001–1009. 338 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongxiu Ji Breakdown of academic impact, for papers by Takahide Arimoto Breakdown of academic impact, for papers by Seon-Ah Ha Breakdown of academic impact, for papers by Di Song Breakdown of academic impact, for papers by Katsumi Tsukazaki Breakdown of academic impact, for papers by Jane M. Turbov Breakdown of academic impact, for papers by A Hizuta Breakdown of academic impact, for papers by Rosalía I. Cordo Russo Breakdown of academic impact, for papers by İlyas Şahin Breakdown of academic impact, for papers by Yoko Aoyagi
Rankless by CCL
2026